Show 1391: Key Steps for Healthy Feet

The People's Pharmacy

Joe and Terry Graedon

Health & Fitness, Medicine, Kids & Family, Alternative Health

4.5 • 934 Ratings

🗓️ 11 July 2024

⏱️ 61 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

This week, Joe and Terry Graedon welcome your questions about keeping your feet healthy. Dr. Jane Andersen is a foot and ankle specialist who will take your calls about a range of podiatric problems. Have you had trouble with plantar fasciitis? You can ask your questions about foot health and share your experience at 888-472-3366 […]

Transcript

Click on a timestamp to play from that location

0:00.0	I'm Joe Gradyton and I'm Terry Grady. Welcome to this podcast of the People's Pharmacy.
0:06.1	You can find previous podcasts and more information on a range of health topics at
0:11.5	People's Pharm pharmacy.com.
0:14.0	We often take our feet for granted until they start to hurt.
0:19.0	How can we keep our feet healthy so they can support us?
0:22.0	This is the people's Pharmacy with Terry and Joe Grady. Sandals, flip-flops, and other warm weather foot gear don't always offer the support you need.
0:40.0	Find out how to select shoes and sandals that do.
0:43.8	If your toes are on view, you might be embarrassed about thick yellow nails.
0:49.8	What should you consider about treating toenail fungus? What's the best approach?
0:55.0	If you have questions about Bunyan's, hammer toes,
0:58.0	plantar fashiatis, or other foot problems,
1:01.0	today's guest has answers.
1:03.0	Coming up, the People's Pharmacy Podiatlines, the FDA has approved the Alzheimer's drug
1:20.3	Don Nanomab. Approval had been delayed because of questions regarding the protocol used in the clinical
1:26.7	trial. Eli Lilly will sell the drug under the brand name Kissunla. This infused medication reduces amyloid plaque in the
1:35.8	brain before starting on Kessunla. Patients will need pet scans to
1:40.5	verify that they have amyloid plaque buildup in their brains.
1:45.0	Unfortunately, this monoclonal antibody does not reverse cognitive decline.
1:51.0	People taking Kissunle in the clinical trial got worse more slowly than those on
1:56.4	placebo. On the standardized 144-point integrated Alzheimer's Disease Rating
2:02.2	scale, people on placebo dropped almost three integrated Alzheimer's Disease rating scale.
2:03.0	People on placebo dropped almost three points more
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Joe and Terry Graedon, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Joe and Terry Graedon and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.